Brief: Taro Provides Results For Quarter Ended June 30, 2020

Taro Pharmaceutical Industries

29/07/2020 23:28

July 29 (Reuters) - Taro Pharmaceutical Industries Ltd
 TARO.N :
    * TARO PROVIDES RESULTS FOR QUARTER ENDED JUNE 30, 2020
    * QUARTERLY SALES $117.6 MILLION
    * QUARTERLY EARNINGS PER SHARE $0.76 EXCLUDING ITEMS
    * ON JULY 23 ACHIEVES GLOBAL RESOLUTION OF DOJ ANTITRUST
INVESTIGATIONS
    * TARO PHARMACEUTICALS U.S.A., AGREED TO PAY $213.3 MILLION
TO
RESOLVE CLAIMS RELATED TO FEDERAL HEALTHCARE PROGRAMS
    * CHARGE OF $418.9 MILLION IS TAKEN IN CURRENT QUARTER
RELATED TO
SETTLEMENT UNDER DOJ ANTITRUST INVESTIGATIONS

Source text for Eikon:  ID:nBw4QFRF4a 
Further company coverage:  TARO.N 

 ((Reuters.Briefs@thomsonreuters.com;))